Zobrazeno 1 - 10
of 1 493
pro vyhledávání: '"P Gisondi"'
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 11, Pp 3071-3081 (2024)
Abstract Introduction Despite advancements in the treatment of psoriasis (PsO), there are few head-to-head studies assessing comparative effectiveness of the newest therapies approved to treat PsO. Our objective was to assess the comparative clinical
Externí odkaz:
https://doaj.org/article/4674a01da9764f109764140e3aba0925
Autor:
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, Laura Atzori, Anna Balato, Federico Bardazzi, Luca Bianchi, Angelo Cattaneo, Andrea Chiricozzi, Maurizio Congedo, Maria Concetta Fargnoli, Claudia Giofrè, Paolo Gisondi, Claudio Guarneri, Serena Lembo, Francesco Loconsole, Giampiero Mazzocchetti, Santo Raffaele Mercuri, Pietro Morrone, Anna Maria Offidani, Giovanni Palazzo, Aurora Parodi, Giovanni Pellacani, Stefano Piaserico, Concetta Potenza, Francesca Prignano, Marco Romanelli, Paola Savoia, Luca Stingeni, Massimo Travaglini, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Antonio Costanzo
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2739-2757 (2024)
Abstract Psoriasis is a chronic, immune-mediated, inflammatory skin disease, associated with multiple comorbidities and psychological and psychiatric disorders. The quality of life of patients with this disease is severely compromised, especially in
Externí odkaz:
https://doaj.org/article/b2dc3d0128c14cb0bc54ca76a47a5f99
Autor:
Ashley C. Rider, Sarah R. Williams, Vivien Jones, Daniel Rebagliati, Kimberly Schertzer, Michael A. Gisondi, Stefanie S. Sebok-Syer
Publikováno v:
Western Journal of Emergency Medicine, Vol 25, Iss 4, Pp 557-564 (2024)
Introduction: Optimizing the performance of emergency department (ED) teams impacts patient care, but the utility of current, team-based performance assessment tools to comprehensively measure this impact is underexplored. In this study we aimed to 1
Externí odkaz:
https://doaj.org/article/4acdf590813047a99a97078a42e9cab3
Autor:
Alexander J. Stratigos, Marie A. Richard, Clio Dessinioti, Carle Paul, Tamar Nijsten, Paolo Gisondi, Carmen Salavastru, Charles Taieb, Myrto Trakatelli, Luis Puig, Thrasyvoulos Tzellos, Dimitrios Ioannides, for the EADV burden of skin diseases project team
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 591-599 (2024)
Abstract Background There is no population‐based evidence on the prevalence and impact of skin diseases in Greece. Objectives To describe the prevalence of 12 main skin diseases and their impact on quality of life (QoL) and feelings of stigmatizati
Externí odkaz:
https://doaj.org/article/0f344796a383446ebcefe1bb72a0350d
Autor:
Marcello Gisondi
Publikováno v:
Democrazia e Diritti Sociali, Vol 2024, Iss 1, Pp 159-177 (2024)
Tis article takes into account the intellectual collaboration of Piero Calamandrei and Norberto Bobbio during the period from the Second World War to 1956. Calamandrei’s and Bobbio’s approaches to culture, law and politics are comparatively inves
Externí odkaz:
https://doaj.org/article/afd57dc90bdd448d9f016532f3fb8f41
Autor:
Lars Erik Kristensen, William Tillett, Peter Nash, Laura C. Coates, Philip J. Mease, Alexis Ogdie, Paolo Gisondi, Barbara Ink, Adam R. Prickett, Rajan Bajracharya, Vanessa Taieb, Nikos Lyris, Jérémy Lambert, Jessica A. Walsh
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 16 (2024)
Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease that causes pain and fatigue, reduces physical function, and negatively impacts health-related quality of life (HRQoL). In the phase III BE OPTIMAL and BE COMPLETE studies, bimek
Externí odkaz:
https://doaj.org/article/8808a439663e4951885d62779c62795b
Autor:
Sarah Alulis, Nicoletta Bernardini, Martina Burlando, Antonio Costanzo, Pier Cesare Francesa Morel, Paolo Gisondi, Francesco Loconsole, Matteo Megna, Giovanni Pellacani, Stefano Piaserico, Francesca Prignano, Ottavio Secchi, Nevena Skroza, Fareen Hassan
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1273-1291 (2024)
Abstract Introduction There are several treatment options for plaque psoriasis (PsO), but uncertainty remains around the optimal sequencing of treatments. The aims of this study were to investigate how adopting a best-treatment-first treatment sequen
Externí odkaz:
https://doaj.org/article/ff75665eae034ad7a5181488eb2829bc
Autor:
Lauren Clarke, Nora O’Neill, Binisha Patel, Samantha Steeman, Gabrielle Segal, Sylvia Bereknyei Merrell, Michael A. Gisondi
Publikováno v:
BMC Medical Education, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Medical trainees (medical students, residents, and fellows) are playing an active role in the development of new curricular initiatives; however, examinations of their advocacy efforts are rarely reported. The purpose of this stud
Externí odkaz:
https://doaj.org/article/a98f6a673e234f8eb7a5db53cd764423
Publikováno v:
Annali di Stomatologia, Vol 15, Iss 3, Pp 123-130 (2024)
Bioactive cements are indicated in many treatments of pediatric dentistry. The present study aims to analyze the efficacy of bioactive cements, in endo-pedodontics, both in deciduous dentition (vital teeth) and in permanent dentition (vital and necro
Externí odkaz:
https://doaj.org/article/2bbea06430f540b083a7b6e85b68c0d8
Autor:
D. Orsini, M. Megna, C. Assorgi, A. Balato, R. Balestri, N. Bernardini, A. Bettacchi, T. Bianchelli, L. Bianchi, G. Buggiani, M. Burlando, AMG. Brunasso, G. Caldarola, N. Cameli, A. Campanati, E. Campione, A. Carugno, K. Chersi, A. Conti, A. Costanzo, E. Cozzani, A. Cuccia, D. D’Amico, G. Dal Bello, E. G. Dall’Olio, P. Dapavo, C. De Simone, E. V. Di Brizzi, A. Di Cesare, V. Dini, M. Esposito, E. Errichetti, M. C. Fargnoli, C. S. Fiorella, A. Foti, Z. Fratton, F. M. Gaiani, P. Gisondi, R. Giuffrida, A. Giunta, C. Guarneri, A. Legori, F. Loconsole, P. Malagoli, A. Narcisi, M. Paolinelli, L. Potestio, F. Prignano, G. Rech, A. Rossi, N. Skroza, F. Trovato, M. Venturini, A. G. Richetta, G. Pellacani, A. Dattola
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: The aim of this multicenter observational study is to report data from real world on the use of bimekizumab in patients aged ≥ 65 years with moderate-to-severe plaque psoriasis. Elderly patients are poorly represented in cli
Externí odkaz:
https://doaj.org/article/7ef04e4cae9b4655894c0414dffd2eb3